Post Doctoral Training Fellow – online adaptive radiotherapy (RT) modelling.

The successful candidate will develop a framework for dynamic plan refinement in real-time for MR-guided RT, acceleration of automated, on-line adaptive treatment planning and devise strategies for quality assurance (QA) of real-time adapted RT.  The final aim of this research is to demonstrate benefit of this cutting-edge technology for patients in collaboration with clinicians and industrial partners.

The projected research is part of a larger program of work funded by a Cancer Research UK (CRUK) program grant and the successful candidate will drive the work forward within a multi-disciplinary team of computer scientists, medical physicists and clinicians in the Joint Department of Physics at the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust. 

About you

The successful candidate must have:

• A PhD in Physics, Engineering or another relevant field and ideally have experience in radiotherapy physics, optimisation algorithms and/or MR imaging and MR-guided RT.

• Candidates who are nearing completion of their PhD may apply, but confirmation of awarded PhD is required within 6 months of employment.

• The ICR has a workforce agreement stating that Postdoctoral Training Fellows can only be employed for up to 7 years as PDTF at the ICR, providing total postdoctoral experience (including previous employment at this level elsewhere) does not exceed 7 years.

Department/Directorate Information

The Radiotherapy Physics Modelling team sits within the Joint Department of Physics - The Institute of Cancer Research, London which spans both The Institute of Cancer Research (ICR) and the Royal Marsden NHS Foundation Trust (RMH).  The team is primarily focused on the development and application of novel technology to further radiotherapy treatments. This includes novel treatment planning techniques, the development of new optimisation algorithms and using modern computer hardware to enable real-time online plan optimisation.